NEOGENOMICS INC — Director's Dealing 2018

Apr 30, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2018-04-19

Reporting Person: Bonello William (VP, Investor Relations)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$8.03	2023-02-26	Common Stock (120500.0)		Direct
Stock Option (Right to Buy)	$7.52	2022-04-28	Common Stock (100000.0)		Direct

Footnotes

F1: On February 26, 2018, Mr. Bonello was granted an option to purchase shares of NeoGenomics, Inc. common stock. The options vest ratably over the first three anniversary dates of the grant date.

F2: On April 28, 2017, Mr. Bonello was granted an option to purchase shares of NeoGenomics, Inc. common stock. The options vest ratably over the first three anniversary dates of the grant date.